Current Status of Some Antituberculosis Drugs and the Development of new Antituberculous Agents with Special Reference to their In Vitro and In Vivo Antimicrobial Activities

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|31|4047-4070

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.31, 2006-11, pp. : 4047-4070

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of New Antituberculous Drugs: Strategies for New Drug Targets and Drug Delivery

By  

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 427-434

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

Development of new antituberculous agents based on new drug targets and structure–activity relationship

By Tomioka Haruaki  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 21-49

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Current Status and Perspective on Drug Targets in Tubercle Bacilli and Drug Design of Antituberculous Agents Based on Structure-Activity Relationship)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4305-4306

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions

By Pelkonen Olavi  

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite